Picture of Read Gene SA logo

RDG Read Gene SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+4.67%
3m-13.77%
6m+53.65%
1yr+32.16%
Volume Change (%)
10d/3m-31.54%
Price vs... (%)
52w High-33.33%
50d MA-5.55%
200d MA+28.82%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-11.12%
Return on Equity-40.83%
Operating Margin-14.67%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Read Gene SA EPS forecast chart

Profile Summary

Read-Gene SA is a Poland-based company active in the biotechnology sector. It is focused on technologies which aim is to detect, prevent and treat malignant tumors. The Company specializes in three fields: chemoprevention, clinical trials and genetic testing. It offers breast cancer, colon cancer and prostate cancer tests, as well as, medical consultancy, DNA tests and supplements. The Company operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o. Its major shareholder is GEN-PAT-MED Sp. z o.o.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 27th, 2005
Public Since
February 12th, 2009
No. of Employees
11
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
9,449,731
Blurred out image of a map
Address
Ul. Akacjowa 2, SZCZECIN, 71-253
Web
https://read-gene.com/
Phone
+48 914334256
Contact
Monika Ewert-Krzemieniewska
Auditors
Firma Audytorsko – Konsultingowa „PER SALDO" Spólka z o.o

RDG Share Price Performance

Upcoming Events for RDG

Similar to RDG

Picture of Airway Medix SA logo

Airway Medix SA

pl flag iconWarsaw Stock Exchange

Picture of Bioton SA logo

Bioton SA

pl flag iconWarsaw Stock Exchange

Picture of Braster SA logo

Braster SA

pl flag iconWarsaw Stock Exchange

Picture of Captor Therapeutics SA logo

Captor Therapeutics SA

pl flag iconWarsaw Stock Exchange

Picture of E-Shopping SA logo

E-Shopping SA

pl flag iconWarsaw Stock Exchange

FAQ